van de Poll-Franse LV - Search Results

1

Impact of cancer diagnosis and treatment on glycaemic control among individuals with colorectal cancer using glucose-lowering drugs.

Zanders MM, van Herk-Sukel MP, Herings RM, van de Poll-Franse LV, Haak HR. Zanders MM, et al. Acta Diabetol. 2016 Oct;53(5):727-35. doi: 10.1007/s00592-016-0863-z. Epub 2016 Apr 18. Acta Diabetol. 2016. PMID: 27087004

2

Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis.

van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. van de Poll-Franse LV, et al. Int J Cancer. 2007 May 1;120(9):1986-92. doi: 10.1002/ijc.22532. Int J Cancer. 2007. PMID: 17230509

3

Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands.

Sukel MP, van de Poll-Franse LV, Nieuwenhuijzen GA, Vreugdenhil G, Herings RM, Coebergh JW, Voogd AC. Sukel MP, et al. Eur J Cancer. 2008 Sep;44(13):1846-54. doi: 10.1016/j.ejca.2008.06.001. Epub 2008 Jul 17. Eur J Cancer. 2008. PMID: 18640030

4

New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System.

van Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE, Vreugdenhil G, Pruijt JF, Coebergh JW, Herings RM. van Herk-Sukel MP, et al. Eur J Cancer. 2010 Jan;46(2):395-404. doi: 10.1016/j.ejca.2009.09.010. Epub 2009 Oct 5. Eur J Cancer. 2010. PMID: 19811904

5

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis.

van Herk-Sukel MP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Coebergh JW, Herings RM. van Herk-Sukel MP, et al. Breast Cancer Res Treat. 2010 Aug;122(3):843-51. doi: 10.1007/s10549-009-0724-3. Epub 2010 Jan 8. Breast Cancer Res Treat. 2010. PMID: 20058066

6

Health-related quality of life among thyroid cancer survivors: a systematic review.

Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV. Husson O, et al. Clin Endocrinol (Oxf). 2011 Oct;75(4):544-54. doi: 10.1111/j.1365-2265.2011.04114.x. Clin Endocrinol (Oxf). 2011. PMID: 21615448 Review.

7

Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis.

van de Poll-Franse LV, Haak HR, Coebergh JW, Janssen-Heijnen ML, Lemmens VE. van de Poll-Franse LV, et al. Diabetologia. 2012 Aug;55(8):2163-72. doi: 10.1007/s00125-012-2555-8. Epub 2012 Apr 24. Diabetologia. 2012. PMID: 22526616 Free PMC article.

8

Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors.

Husson O, Haak HR, Mols F, Nieuwenhuijzen GA, Nieuwlaat WA, Reemst PH, Huysmans DA, Toorians AW, van de Poll-Franse LV. Husson O, et al. Acta Oncol. 2013 Feb;52(2):447-54. doi: 10.3109/0284186X.2012.718445. Epub 2012 Sep 27. Acta Oncol. 2013. PMID: 23013266

9

Effect of diabetes on endometrial cancer recurrence and survival.

Zanders MM, Boll D, van Steenbergen LN, van de Poll-Franse LV, Haak HR. Zanders MM, et al. Maturitas. 2013 Jan;74(1):37-43. doi: 10.1016/j.maturitas.2012.10.007. Epub 2012 Nov 12. Maturitas. 2013. PMID: 23153683

10

Husson O, Haak HR, Buffart LM, Nieuwlaat WA, Oranje WA, Mols F, Kuijpens JL, Coebergh JW, van de Poll-Franse LV. Husson O, et al. Acta Oncol. 2013 Feb;52(2):249-58. doi: 10.3109/0284186X.2012.741326. Epub 2012 Nov 26. Acta Oncol. 2013. PMID: 23181387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters